People

Inhaler monitoring company Adherium has named Peter Stratford as CEO and Mike Motion as Chief Commercial Officer, replacing interim CEO Jeremy Curnock Cook and interim CCO Bill Hunter. Stratford was most recently Head of Innovation at healthcare company BTG, which has now been acquired by Boston Scientific. Motion was most recently Head of Varithena, a BTG … [Read more...] about Adherium names new CEO, Chief Commercial Officer

Iliad Biotechnology has announced the appointment of Cheryl Keech as Chief Medical Officer and Executive VP of Clinical Research; she will be responsible for clinical studies of the company's pipeline products, including the BPZE1 live attenuated intranasal pertussis vaccine. The company said that a Phase 2b trial of BPZE1 has completed enrollment. Keech was most … [Read more...] about Iliad Biotechnologies appoints Cheryl Keech as Chief Medical Officer and Executive VP of Clinical Research

Savara has announced the appointment of Badrul Chowdhury, as Chief Medical Officer, a newly created position. From 2002-2018, Chowdhury was the Director of the FDA's Division of Pulmonary, Allergy, and Rheumatology Products, Center for Drug Evaluation and Research (CDER). Most recently, he was Senior VP, Chief Physician-Scientist for Respiratory, Inflammation, … [Read more...] about Savara appoints Badrul Chowdhury Chief Medical Officer

Insmed Incorporated has announced the appointment of Clementia Pharmaceuticals President and CEO Clarissa Desjardins to its board of directors and the promotions of Roger Adsett to Chief Operating Officer and Drayton Wise to Senior VP, Head of United States. The company also recently announced the appointment of Martina Flammer as Chief Medical Officer and provided an … [Read more...] about Insmed announces appointment of new board member, promotions of two executives

 AZTherapies has named Ernest D. Penachio to the newly created position of VP of Manufacturing Operations and CMC to oversee clinical and pre-commercial manufacturing, scale-up, and CMC content development for the company's ALZT-OP1 inhaled cromolyn/oral ibuprofen combination therapy for the treatment of Alzheimer's disease, which is in Phase 3 development. … [Read more...] about AZTherapies names Ernest Penachio VP of Manufacturing Operations and CMC

Inhaled drug developer Pulmatrix has announced the appointment of Nocion Therapeutics CEO Rick Batycky to its board of directors. Batycky was a founder of Civitas Therapeutics, which developed Inbrija inhaled levodopa and which was acquired by Acorda in 2014. Prior to serving as Chief Scientific Officer at Civitas and then Chief Technology Officer at Acorda, Batycky … [Read more...] about Rick Batycky joins Pulmatrix board of directors

Liquidia Technologies has announced the appointment of AbbVie VP of Global Commercial Development Katie Rielly-Gauvin to its board of directors for a term that will extend until company's 2020 annual meeting. Prior to her position at AbbVie, Rielly-Gauvin held various executive positions at Johnson & Johnson companies over a number of therapeutic areas. In … [Read more...] about Liquidia adds Katie Rielly-Gauvin to its board of directors

Inhaled nitric oxide developer Third Pole Therapeutics has announced the appointment of Bill Athenson as its new Chief Executive Officer, succeeding founding CEO David Zapol. Athenson most recently served as CEO of Three Lakes Partners; his previous experience includes 13 years as the VP, Global Sales, Marketing and Business Development at Nanosphere Inc. In … [Read more...] about Third Pole Therapeutics names Bill Athenson as CEO

Inhaled drug developer Vectura has announced the appointment of former Catalent executive Will Downie as CEO and Executive Director. Downie was most recently Senior VP, Global Sales and Marketing at Catalent and previously served in various roles at GE Healthcare, Amersham Health, and Quintiles. In July 2019, Vectura announced that it would focus its R&D … [Read more...] about Vectura names Will Downie as CEO and Executive Director